Creosote Combination

FDA Drug Profile — Creosote Combination 9254

Creosote Combination is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Creosote Combination 9254. Available dosage form: liquid.

Drug Details

Generic Name
Creosote Combination
Brand Names
Creosote Combination 9254
Application Number
Sponsor
Professional Complementary Health Formulas
NDC Codes
1
Dosage Forms
LIQUID
Routes
ORAL
Active Ingredients
ACONITUM NAPELLUS WHOLE, AMARYLLIS BELLADONNA WHOLE, BRYONIA ALBA ROOT, HYOSCYAMUS NIGER, IPECAC, LOBELIA INFLATA WHOLE, LOBARIA PULMONARIA, PHOSPHORUS, ANTIMONY POTASSIUM TARTRATE, WOOD CREOSOTE, SILICON DIOXIDE, HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED, CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)

Indications and Usage

INDICATIONS For the temporary relief of coughing, wheezing, chills, sweats, fatigue, minor aches and pains, and irritation, tenderness or mild pain in the nose or throat.*

Warnings

WARNINGS If symptoms do not improve or are accompanied by fever, consult a doctor. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.